Most Popular Reports On WNDM

Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Loading...
Please wait... loading results
Business Description
Wound Management Technologies, Inc. is engaged in developing and marketing products for the advanced wound care market, as pursued through the Company’s wholly owned subsidiary, Wound Care Innovations, LLC (WCI), which brings a mix of products, procedures and expertise to the wound care arena and surgical wounds. The Company’s CellerateRX is cleared by the Food and Drug Administration (FDA) as a medical device for use on all acute and chronic wounds, except third degree burns, and is ready for distribution in both gel and powder form. CellerateRX is available without a prescription and the wound care products are approved for reimbursement under Medicare Part B. CellerateRX wound care and surgical products are sold through independent distributors, distributor organizations, healthcare distributors, representatives and through inside sales activities.